Home Cart 0 Sign in  
X

[ CAS No. 102359-00-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 102359-00-2
Chemical Structure| 102359-00-2
Chemical Structure| 102359-00-2
Structure of 102359-00-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 102359-00-2 ]

Related Doc. of [ 102359-00-2 ]

Alternatived Products of [ 102359-00-2 ]

Product Details of [ 102359-00-2 ]

CAS No. :102359-00-2 MDL No. :MFCD03411961
Formula : C9H7NO3 Boiling Point : -
Linear Structure Formula :- InChI Key :LLLKBUWXODIMEW-UHFFFAOYSA-N
M.W : 177.16 Pubchem ID :2773318
Synonyms :

Calculated chemistry of [ 102359-00-2 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.11
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 48.69
TPSA : 66.4 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.89 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.97
Log Po/w (XLOGP3) : 0.69
Log Po/w (WLOGP) : 0.31
Log Po/w (MLOGP) : 0.72
Log Po/w (SILICOS-IT) : 1.2
Consensus Log Po/w : 0.78

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -1.65
Solubility : 3.98 mg/ml ; 0.0225 mol/l
Class : Very soluble
Log S (Ali) : -1.66
Solubility : 3.86 mg/ml ; 0.0218 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.26
Solubility : 0.974 mg/ml ; 0.0055 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.52

Safety of [ 102359-00-2 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280 UN#:N/A
Hazard Statements:H302-H317 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 102359-00-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 102359-00-2 ]
  • Downstream synthetic route of [ 102359-00-2 ]

[ 102359-00-2 ] Synthesis Path-Upstream   1~7

  • 1
  • [ 65435-04-3 ]
  • [ 102359-00-2 ]
YieldReaction ConditionsOperation in experiment
97%
Stage #1: at 80 - 90℃; for 3 h;
Stage #2: With sodium hydroxide In water at 70 - 80℃; for 3 h;
EXAMPLE 13 (FROM TABLE 3)
3-[4-(2-Carboxy-ethyl)-3-methyl-1H-pyrrol-2-ylmethylene]-2-oxo-2,3-dihydro-1H-indole-5-carboxylic acid
2-Oxindole (6.7 g) was added to a stirred suspension of 23 g aluminum chloride in 30 mL dichloroethane in an ice bath.
Chloroacetyl chloride (11.3 g) was slowly added and hydrogen chloride gas was evolved.
After ten minutes of stirring, the reaction was warmed to 40..50° C. for 1.5 hours.
Thin layer chromatography (ethyl acetate, silica gel) showed no remaining starting material.
The mixture was cooled to room temperature and poured into ice water.
The precipitate was collected by vacuum filtration, washed with water and dried under vacuum to give 10.3 g (98percent) of 5-chloroacetyl-2-oxindole as an off-white solid.
97%
Stage #1: at 80 - 90℃; for 3 h;
Stage #2: at 70 - 80℃; for 3 h;
Stage #3: With hydrogenchloride In water
A suspension of 93 g of 5-chloroacetyl-2-oxindole was stirred in 90 mL pyridine at 80 to 90° C. for 3 hours then cooled to room temperature. The precipitate was collected by vacuum filtration and washed with 20 mL ethanol. The solid was dissolved in 90 mL 2.5N sodium hydroxide and stirred at 70 to 80° C. for 3 hours. The mixture was cooled to room temperature and acidified to pH 2 with 0.5 N hydrochloric acid. The precipitate was collected by vacuum filtration and washed thoroughly with water to give crude 5-carboxy-2-oxindole as a dark brown solid. After standing overnight the filtrate yielded 2 g of 5-carboxy-2-oxindole as a yellow solid. The crude dark brown product was dissolved in hot methanol, the insoluble material removed by filtration and the filtrate concentrated to give 5.6 g of 5-carboxy-2-oxindole as a brown solid. The combined yield was 97percent.
97% With pyridine; sodium hydroxide In water at 70 - 90℃; for 6 h; A suspension of 9.3 g of 5-chloroacetyl-2-oxindole was stirred in 90 ML pyridine at 80 to 90° C. for 3 hours then cooled to room temperature..
The precipitate was collected by vacuum filtration and washed with 20 ML ethanol..
The solid was dissolved in 90 ML 2.5N sodium hydroxide and stirred at 70 to 80° C. for 3 hours..
The mixture was cooled to room temperature and acidified to PH 2 with 0.5 N hydrochloric acid..
The precipitate was collected by vacuum filtration and washed thoroughly with water to give crude 5-carboxy-2-oxindole as a dark brown solid..
After standing overnight the filtrate yielded 2 g of 5-carboxy-2-oxindole as a yellow solid..
The crude dark brown product was dissolved in hot methanol, the insoluble material removed by filtration and the filtrate concentrated to give 5.6 g of 5-carboxy-2-oxindole as a brown solid..
The combined yield was 97percent.
Reference: [1] Patent: US6878733, 2005, B1, . Location in patent: Page/Page column 220
[2] Patent: US6878733, 2005, B1, . Location in patent: Page/Page column 172
[3] Patent: US6350754, 2002, B2, . Location in patent: Page column 24
[4] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 3, p. 745 - 750
[5] Chemical and Pharmaceutical Bulletin, 1988, vol. 36, # 6, p. 2253 - 2258
[6] Journal of Medicinal Chemistry, 1999, vol. 42, # 25, p. 5120 - 5130
[7] Patent: US2003/69421, 2003, A1,
[8] Patent: US2002/183364, 2002, A1,
[9] Patent: US6395734, 2002, B1,
[10] Patent: US6051593, 2000, A,
[11] Patent: US6486185, 2002, B1,
[12] Patent: US6114371, 2000, A,
[13] Patent: US4737501, 1988, A,
[14] Patent: EP168003, 1991, B1,
[15] Patent: EP2130829, 2009, A1, . Location in patent: Page/Page column 19-20
[16] Bioorganic and Medicinal Chemistry, 2017, vol. 25, # 13, p. 3500 - 3511
[17] European Journal of Medicinal Chemistry, 2018, vol. 155, p. 197 - 209
  • 2
  • [ 199328-10-4 ]
  • [ 102359-00-2 ]
YieldReaction ConditionsOperation in experiment
97% With hydrogenchloride In water at 100℃; Step 1: A mixture of compound 1 (200 mg, 1.0 mmol) and HC1 (2.0 M in H20, 5 mL) was heated to 100°C for overnight. The mixture was concentrated to get compound 2 (180 mg, 97percent) as light yellow solid.
80% With sodium hydroxide In methanol; water at 0 - 20℃; for 14 h; Into a 50-mL round-bottom flask was placed methyl 2-oxo-2,3-dihydro-1H- indole-5-carboxylate (800 mg, 4.18 mmol, 1.00 equiv) and methanol (10 mL). This was followed by the addition of a solution of NaOH (670 mg, 16.75 mmol, 4.00 equiv) in water (10 mL) dropwise with stirring at 0oC. The resulting solution was stirred for 14 h at 20oC. The mixture was then concentrated under vacuum and the residue taken up in 20 mL of H2O. This was washed with 2x5 mL of dichloromethane. The pH was adjusted to 4 with hydrochloric acid (1 N) and extracted with 5x50 mL of ethyl acetate and the organic layers combined. Concentration resulted in 592 mg (80percent) of 2-oxo-2,3-dihydro- 1H-indole-5-carboxylic acid as a yellow solid
78% With sodium hydroxide In methanol; water Step 2:
Synthesis of 5-Carboxy-2-oxindole. 5-Methoxycarbonyl-2-oxindole (1 g) and 1 g of sodium hydroxide in 20 mL of methanol was refluxed for 3 hours.
The reaction mixture was cooled and concentrated to dryness.
The residue was dissolved in water and extracted twice with ethyl acetate.
The aqueous layer was acidified with 6 N hydrochloric acid and the precipitated solid collected, washed with water, and dried to give 0.7 g (78percent) of the title compound as an off-white solid.
Reference: [1] Patent: WO2014/121062, 2014, A1, . Location in patent: Page/Page column 30
[2] Patent: KR2017/45749, 2017, A, . Location in patent: Paragraph 0952; 0955-0957
[3] Patent: US6147106, 2000, A,
  • 3
  • [ 1670-81-1 ]
  • [ 102359-00-2 ]
YieldReaction ConditionsOperation in experiment
95%
Stage #1: With bromine; acetic acid; lithium bromide In ethanol; <i>tert</i>-butyl alcohol at 15℃; for 2.25 h; Cooling with ice
Stage #2: With zinc In ethanol; <i>tert</i>-butyl alcohol at 20℃; for 16 h;
Oxindole-5-carboxylic acidIndole-5-carboxylic acid 5.00g (31.0 mmol) solution in ethanol 99percent 120mL and tert-butanol 180mL in a 1L RB flask was cooled on ice bath to +5 °C. Meanwhile, a solution of lithium bromide 9.0g (103.6 mmol) in neat acetic acid 60mL was placed into an addition funnel. Neat bromine 5.0 mL (16.0g; 100.1 mmol) was then charged to this LiBr solution and the resulting bromine + LiBr solution was dropwise added into the vigorously stirred indolecarboxylic acid solution at +5 °C over a 90 min period. (After a complete addition the addition funnel was then washed with EtOH (2 x 5 mL) and the washings were added to the reaction mix). At the end of the bromine addition the cooling bath was let to expire and the reaction mix was stirred at +5 to +15 °C bath for 1 hour and at 15 °C for additional 15 min. The reaction mixture was then diluted with additional acetic acid lOOmL. Zn dust 20g [Aldrich; <10 μΜ] (306 mmol) was added in one portion (gas evolution) and the mixture was stirred in an open flask on ambient water bath overnight (16 hours). The next day, the precipitated solids were collected by filtration, washed with ethanol and dried by suction. The solid (containing a mix of the product, unreacted Zn metal and Zn salts) was transferred into a large beaker on a hotplate, suspended in boiling methanol (300mL) and filtered. The extraction with boiling methanol was repeated twice more, to separate the unreacted Zn metal from the product. The combined methanolic filtrates were evaporated to dryness. Separately, the acetic acid + LiBr - containing filtrates from the reaction mix were concentrated to a small volume on rotovap and the produced salt-rich residue was diluted with water 0.6L and acidified with 6M HC1 to about pH= 1.5. This mixture was then combined with the evaporation residue obtained from the methanolic filtrates. The solids in the flask were re-suspended by a brief sonication (5 min) and the slurry was cooled down on ice bath, then placed into a freezer (-20 °C) for 4 hours. The precipitated product was collected by filtration, washed with ice-cold water, dried by suction and on highvac. Y=5.23g (95percent) of a light tan solid. 1H-NMR (d6-DMSO, 400MHz): 12.58 (br s, 1H), 10.72(s, 1H), 7.82 (dd, 8.3Hz, 1.6Hz, 1H), 7.75 (s, 1H), 6.88 (d, 8.3Hz, 1H), 3.54 (s, 2H)
Reference: [1] Patent: WO2011/119777, 2011, A2, . Location in patent: Page/Page column 29-30
  • 4
  • [ 25128-32-9 ]
  • [ 102359-00-2 ]
Reference: [1] Medicinal Chemistry Research, 2018, vol. 27, # 1, p. 161 - 170
  • 5
  • [ 59-48-3 ]
  • [ 102359-00-2 ]
Reference: [1] Journal of Medicinal Chemistry, 1999, vol. 42, # 25, p. 5120 - 5130
[2] Bioorganic and Medicinal Chemistry, 2017, vol. 25, # 13, p. 3500 - 3511
[3] European Journal of Medicinal Chemistry, 2018, vol. 155, p. 197 - 209
  • 6
  • [ 150-13-0 ]
  • [ 102359-00-2 ]
Reference: [1] Medicinal Chemistry Research, 2018, vol. 27, # 1, p. 161 - 170
  • 7
  • [ 17122-78-0 ]
  • [ 102359-00-2 ]
Reference: [1] Medicinal Chemistry Research, 2018, vol. 27, # 1, p. 161 - 170
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 102359-00-2 ]

Amides

Chemical Structure| 167627-04-5

[ 167627-04-5 ]

7-Methyl-2-oxoindoline-5-carboxylic acid

Similarity: 1.00

Chemical Structure| 1225693-10-6

[ 1225693-10-6 ]

7-Ethyl-2-oxoindoline-5-carboxylic acid

Similarity: 1.00

Chemical Structure| 25369-43-1

[ 25369-43-1 ]

2-Oxoindoline-7-carboxylic acid

Similarity: 0.98

Chemical Structure| 334952-09-9

[ 334952-09-9 ]

2-Oxoindoline-6-carboxylic acid

Similarity: 0.98

Chemical Structure| 28565-98-2

[ 28565-98-2 ]

2-(2-Phenylacetamido)benzoic acid

Similarity: 0.95

Carboxylic Acids

Chemical Structure| 167627-04-5

[ 167627-04-5 ]

7-Methyl-2-oxoindoline-5-carboxylic acid

Similarity: 1.00

Chemical Structure| 1225693-10-6

[ 1225693-10-6 ]

7-Ethyl-2-oxoindoline-5-carboxylic acid

Similarity: 1.00

Chemical Structure| 25369-43-1

[ 25369-43-1 ]

2-Oxoindoline-7-carboxylic acid

Similarity: 0.98

Chemical Structure| 334952-09-9

[ 334952-09-9 ]

2-Oxoindoline-6-carboxylic acid

Similarity: 0.98

Chemical Structure| 28565-98-2

[ 28565-98-2 ]

2-(2-Phenylacetamido)benzoic acid

Similarity: 0.95

Related Parent Nucleus of
[ 102359-00-2 ]

Indolines

Chemical Structure| 167627-04-5

[ 167627-04-5 ]

7-Methyl-2-oxoindoline-5-carboxylic acid

Similarity: 1.00

Chemical Structure| 1225693-10-6

[ 1225693-10-6 ]

7-Ethyl-2-oxoindoline-5-carboxylic acid

Similarity: 1.00

Chemical Structure| 25369-43-1

[ 25369-43-1 ]

2-Oxoindoline-7-carboxylic acid

Similarity: 0.98

Chemical Structure| 334952-09-9

[ 334952-09-9 ]

2-Oxoindoline-6-carboxylic acid

Similarity: 0.98

Chemical Structure| 138328-27-5

[ 138328-27-5 ]

1-Methyl-2-oxoindoline-6-carboxylic acid

Similarity: 0.93